Stability and ocular tolerance of cyclophosphamide-loaded nanospheres

Journal of Microencapsulation

Volumn 21, Issue 2, 2004, Pages 213-223

  Salgueiro, A ^a   Egea, M A ^a   Espina, M ^a   Valls, O ^a   García, Marisa L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cyclophosphamide; Drug delivery; Enzyme degradation; Nanospheres; Ocular tolerance; Stability

Indexed keywords

BUFFER; CYCLOPHOSPHAMIDE; DEXTRAN 70; ENBUCRILATE; ESTERASE; FLURBIPROFEN; IMMUNOSUPPRESSIVE AGENT; LYSOZYME; NANOPARTICLE; POLOXAMER; POLYACRYLIC ACID; POLYCAPROLACTONE; POLYMER; SODIUM HYDROXIDE; SOLVENT;

ANIMAL EXPERIMENT; ARTICLE; CHEMOSIS; COLLOID; CONTROLLED STUDY; CORNEA OPACITY; DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; DRUG TOLERANCE; EYE IRRITATION; IN VIVO STUDY; IRITIS; MALE; MICROMORPHOLOGY; MORPHOMETRICS; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; SURFACE PROPERTY; SUSPENSION; TEMPERATURE MEASUREMENT;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLOPHOSPHAMIDE; DRUG STABILITY; ENBUCRILATE; EYE; HYDROGEN-ION CONCENTRATION; IMMUNOSUPPRESSIVE AGENTS; NANOTUBES; PARTICLE SIZE; RABBITS; TEMPERATURE;

EID: 1642487697     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/02652040310001637866     Document Type: Article

References (35)

1. Abraham, N. G., Lin, J. H. C., Dunn, M. W. and Schwartzman, M. L., 1987, Presence of heme-oxygenase and NADPH-cytochrome P-450 reductase in human corneal epithelium. Investigations in Ophthalmology and Visual Sciences, 28, 1464-1472.
2. Baeyen, S. V. and Gurny, R., 1997, Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. Pharmacologica Acta Helvetica, 72, 191-202.
3. Behan, N., Birkinshaw, C. and Clarke, N., 2001, Poly n-butyl cyanoacrylate nanoparticles, a mechanistic study of polymerisation and particle formation. Biomaterials, 22, 1335-1344.
4. Brooke, D., Bequette, R. J. and Davis, R. E., 1973, Chemical stability of ciclophosphamide in parenteral solutions. American Journal of Hospital Pharmacology, 30, 134-137.
5. Calvo, P., Vila-Jato, J. L. and Alonso, M. J., 1997, Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles, stabilization approaches. Biomaterials, 18, 1305-1310.
6. Chang, S. C. and Lee, V. H. L., 1983, Influence of chain length on the in vitro hydrolysis of model ester prodrugs by ocular esterases. Current Eye Research, 2, 651-656.
7. Chiarini, A., Tartarini, A. and Fini, A., 1984, pH-solubility relationship and partition coefficients for some anti-inflammatory arylaliphatic acids. Archives Pharmazie, 317, 268-273.
8. Couvreur, P., Grislain, L., Lenearts, V., Brausseut, F., Guiot, P. and Biernacki, A., 1986, Biodegradable polymeric nanoparticles as drug carrier for antitumor agents. In Polymeric Nanoparticles and Microspheres, edited by P. Guiot and P. Couvreur (Boca Raton: CRC Press), pp. 27-93.
9. Couvreur, P., Kante, B., Roland, P., Guiot, P., Baudin, P. and Speiser, P., 1979, Polycyanoacrylate nanocapsules as potential lysosmotropic carrier, preparation, morphological and sortive properties. Journal of Pharmaceutics and Pharmacology, 31, 331-332.
10. Donnelly, E. F., Johnston, D. S. and Pepper, D. C., 1977, Ionic and zwitteronic polymerisation of n-alkyl-2-cyanoacrylates. Polymer Letters, 15, 339-405.
11. Draize, J. H., Woodard, E. and Calvery, H. O., 1944, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology and Experimental Therapeutics, 82, 377-390.
12. Egea, M. A., Gamisans, F., Valero, J. Espina, M. and García, M. L., 1994, Entrapment of cisplatin into biodegradable polyalkylcyanoacrylate nanoparticles. Il Farmaco, 49, 211-217.
13. Fraunfelder, F. T., 1989, Drug Induced Ocular Side Effects and Drug Interactions (Philadelphia: Lea Fébiger), pp 386-388.
14. Fresta, M., Fontana, G., Bucolo, C., Cavallero, G., Giammona, G. and Puglisi, G., 2001, Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. Journal of Pharmaceutical Sciences, 90, 288-297.
15. Fresta, M. and Puglisi, G., 1994, Association of netilmicin sulphate to poly (alkylcyanoacrylate) nanoparticles. Factors influencing particle delivery behaviour. Drug Development and Industrial Pharmacy, 20, 2227-2243.
16. Gamisans, F., Lacoulonche, F., Chauvet, A., Espina, M., García, M. L. and Egea, M. A., 1999, Flurbiprofen-loaded nanospheres, analysis of the matrix structure by thermal methods. International Journal of Pharmaceutics, 179, 37-48.
17. Golubovic, S. and Radmanovic, B. Z., 1988, Increase of corneal graft survival by use of topically immunosuppressive agents in rabbits. Graefes Archives of Clinical and Experimental Ophthalmology, 226, 288-290.
18. Hall, J. M., Ohno, S. and Pribnow, J. F., 1977, The effect of cyclophosphamide on an ocular immune response. Clinical and Experimental Immunology, 30, 309-316.
19. Hirano, T., Ringsdorf, H. and Zaharko, D. S., 1980, Antitumor activity of monomeric and polymeric cyclophosphamide derivatives compared with in vitro hydrolysis. Cancer Research, 40, 2263-2267.
20. Kabanov, A. V, Batrakova, E. V. and Miller, D. W., 2003, Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Advanced Drug Delivery Reviews, 55, 151-164.
21. Kay, J. H. and Calandra, J. C., 1962, Interpretation of eye irritation test. Journal of the Society of Cosmetics Chemistry, 13, 281-289.
22. Kreuter, J., 1983, Physicochemical characterization of polyacrylic nanoparticles. International Journal of Pharmaceutics, 14, 43-58.
23. Lee, V. H., 1985, Topical ocular drug delivery systems, recent advances and future prospective. Pharmacology International, 6, 135-138.
24. Ludwig, A. and Van Ooteghem, M., 1987, The influence of the osmolality on the pre-corneal retention of ophthalmic solutions. Journal de Pharmacie de Belgique, 42, 259.
25. Marchal-Heussler, L., Maincent, P., Hoffman, M., Spittler, and Couvreur, P., 1990, Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations. International Journal of Pharmaceutics, 58, 115-122.
26. Masson, V., Maurin, F, Devissaguet, J. P. and Fessi, M., 1996, Stability of poly-E-caprolactone nanospheres in sterile aqueous media. International Journal of Pharmaceutics, 139, 113-123.
27. Müller, R. H., Lherm, C., Herbort, J., Blunk, T. and Couvreur, P., 1992, Alkylcyanoacrylate drug carriers: Physicochemical characterization of nanoparticles with different alkyl chain length. International Journal of Pharmaceutics, 84, 1-11.
28. Salgueiro, A., Egea, M. A., Valls, R., Espina, M. and García, M. L., 1999, An inductively coupled method for determination of cyclophosphamide loaded to polymeric systems. Journal of Pharmaceutical and Biomedical Analysis, 21, 611-618.
29. Salgueiro, M. A., García, M. L., Espina, M., Valls, O. and Egea, M. A., 2000, Asociación de ciclofosfamida a nanoesferas de polibutilcianoacrilato. Ciencia y Tecnología Pharmaceutica, 10, 14-19.
30. Scherer, D., Kreuter, J. and Robinson, J. R., 1994, Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles. International Journal of Pharmaceutics, 101, 165-168.
31. Schoenwald, R. D. and Stewart, P., 1980, Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. Journal of Pharmaceutical Sciences, 69, 391-394.
32. Shichi, H., Mahalak, S. M., Sakamoto, S. and Sugiyama, T, 1991, Immunocytochemical study of phenobarbital and 3-methylcholanthrene-inducible Cytochrome P450 Isozymes in primary cultures or porcine ciliary epithelium. Current Eye Research, 10, 779-788.
33. Stein, M. and Hamacher, E., 1992, Degradation of polybutyl-2-cyanoacrylate microparticles. International Journal of Pharmaceutics, 80, R11-R13.
34. Tanaka, H., Hasegawa, T., Miichi, H., Hirayama, M. and Hayashi, S., 1985, Rabbit blinking test. Journal of the Eye, 2, 1127-1129.
35. Taniguchi, K., Yakamoto, Y., Itakura, K., Milchi, H. and Hayashi, S., 1988, Assessment of ocular irritability of liposome preparations. Journal of Pharmacobiological Dynamics, 11, 607-611.